Healthcare research from Johnson & Johnson, page 9
A filtered view. Show the full list.
Refine
Listings
-
Clinical trial reportInflammatory bowel diseases
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe international journal of neuropsychopharmacology
Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source
Clinical careAdded
-
Clinical trial reportThe international journal of neuropsychopharmacology
Weight and metabolic changes in patients with schizophrenia treated with paliperidone palmitate 6-month formulation versus paliperidone palmitate 3-month formulation: a post-hoc analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of the American Medical Informatics Association : JAMIA
Med.ai ASK: an agentic system for biomedical question answering
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ArticleJournal of the American Medical Informatics Association : JAMIA
REWARD-an open-source framework for identifying the unknown benefits of existing medications to inform drug discovery, development, and repurposing
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ArticleJapanese journal of clinical oncology
Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleThe oncologist
Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleThe oncologist
Biomarker testing patterns among patients newly diagnosed with metastatic non-small cell lung cancer, prostate cancer, and bladder cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleRheumatology (Oxford, England)
Prediction of foetal atrioventricular conduction using maternal disease, treatment and anti-Ro/La autoantibody levels
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleSkin health and disease
Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trials
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleToxicological sciences : an official journal of the Society of Toxicology
Safetyome and specialized panels for over 3,000 phenotypes: a systematic and translational approach using human genetics and pharmacology
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ArticleThe Journal of dermatology
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBioethics
The Changing Application of Vulnerability Across the Different Phases of Clinical Research
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ReviewClinical and translational science
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleDiabetes, obesity & metabolism
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportEuropean journal of neurology
Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
LetterJournal of the European Academy of Dermatology and Venereology : JEADV
Caution is needed for systematic reviews and interpretation of preference studies
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADV
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleScience (New York, N.Y.)
Couple-close: Unified approach to semisaturated cyclic scaffolds
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Princeton University. Affiliation source
Other scienceAdded
-
ArticleArchives of disease in childhood. Fetal and neonatal edition
Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBMJ open
Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleBMJ open
Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBMJ open
Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleLupus science & medicine
Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded